Date | Insider | Price | Amount |
---|---|---|---|
4-21-2023 Insider Buy |
Catherine M. Vaczy EVP GC Chief Strategy Officer |
$1.07 CAGR » |
$21,478.00 20,000 shares |
4-21-2023 Insider Buy |
John Rodney Varner Chairman, President and CEO |
$1.05 CAGR » |
$20,045.00 19,000 shares |
9-5-2019 Insider Buy |
John Rodney Varner Chief Executive Officer |
$0.89 CAGR » |
$1,594.62 1,800 shares |
3-29-2018 Insider Buy |
Jack A. Roth >10% Owner |
$5.00 CAGR » |
$200,000.00 40,000 shares |
3-29-2018 Insider Buy |
John Rodney Varner Chief Executive Officer |
$5.00 CAGR » |
$50,000.00 10,000 shares |
Also See: Institutional Holders of GNPX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/24/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $35.68 | |
End price/share: | $2.21 | |
Dividends collected/share: | $0.00 | |
Total return: | -93.81% | |
Average Annual Total Return: | -93.66% | |
Starting investment: | $10,000.00 | |
Ending investment: | $619.79 | |
Years: | 1.01 |
Genprex Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Genprex insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GNPX
Free GNPX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |